U.S. Physical Therapy Expects The Company's Adjusted EBITDA For 2023 To Be Within Its Previously Provided Guidance Range Of $75M-$80M
Portfolio Pulse from Benzinga Newsdesk
U.S. Physical Therapy (USPH) expects its Adjusted EBITDA for 2023 to be within the previously provided guidance range of $75M-$80M. The final figure will depend on the strength of volumes in Q4 and the growth in net rate from Q3 to Q4. The guidance excludes future acquisitions.
November 07, 2023 | 9:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
U.S. Physical Therapy maintains its 2023 Adjusted EBITDA guidance of $75M-$80M. The final figure will depend on Q4 volumes and net rate growth.
The company's earnings guidance for 2023 remains unchanged, which indicates stability in their financial outlook. However, the final figure is dependent on Q4 volumes and net rate growth, introducing some uncertainty. This news is highly relevant to USPH as it directly pertains to their financial guidance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100